#320 – AMA 64: New insights on GLP-1 agonists...

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this special episode, Peter takes a deep dive into obicetrapib, an investigational drug that has captured his attention and renewed interest in a ...  Show more

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter Layne Norton is a nutrition scientist and accomplished power athlete,who returns to The Drive for a conversation that departs from the show's usual ...  Show more

Dr. Gil Blander and Ashley Reaver dive into the science behind GLP-1 agonists, a class of drugs originally developed for type 2 diabetes but now widely used for weight management and longevity. They explore how these medications work, their effects on appetite, metabolism, and ...

How she got into practice and how she got into the GLP-1 space. (2:25) Peptide vs a drug. (10:45) The dose matters. (11:18) The GLP-1 deficiency factors. (15:50) Running into the resistance wall. (20:11) The downstream effects of GLP-1s on our metabolism. (22:15) The musculoskele ...  Show more

<span style="font-size: 12.0pt; line-height: 107%;">It's time for another Q&A episode. I'm answering listener questions about bioidentical HRT, the risks associated with oral estrogens, and so much more. Additionally, we'l ...

Send a textDr. Jade Teta interviews Dr. Lauren Fitzgerald, an MD specializing in functional medicine, about the use of GLP-1 agonists (semaglutide, Tirzapatide, etc) for weight loss. Dr. Fitzgerald shares her experience using these compounds and how they have helped her and her p ...  Show more